What are the anesthesia considerations for a patient with empty sella syndrome?

Anesthesia Considerations for Empty Sella Syndrome

Patients with empty sella syndrome require comprehensive preoperative pituitary function testing—particularly adrenal axis evaluation—because 29–40.5% have at least one hormone deficiency despite being asymptomatic, and unrecognized hypocortisolism (present in 13.5–17.7% of cases) can precipitate life-threatening perioperative adrenal crisis or refractory vasodilatory shock. 1, 2

Critical Preoperative Endocrine Assessment

Adrenal Axis (Highest Priority)

• Obtain morning (≈8 AM) serum cortisol and ACTH before any elective procedure, as secondary adrenal insufficiency occurs in 13.5–17.7% of empty sella patients regardless of symptoms. 1, 2
• If morning cortisol is low (<5–10 µg/dL), confirm with dynamic testing (ACTH stimulation test or insulin-tolerance test) to definitively diagnose adrenal insufficiency. 1
• Administer stress-dose corticosteroids perioperatively if adrenal insufficiency is confirmed or suspected, as metabolic stress can unmask posterior pituitary hypofunction and precipitate profound vasodilatory hypotension unresponsive to fluid resuscitation and inotropes. 3

Posterior Pituitary Function

• Screen for diabetes insipidus through clinical history (polyuria, polydipsia) and baseline electrolytes, as central diabetes insipidus occurs in approximately 0.9–1.7% of empty sella patients. 4, 5
• If diabetes insipidus is present, administer desmopressin acetate (5 µg intranasally) 1 hour before anesthesia to maintain fluid balance during the perioperative period. 6
• Monitor fluid status meticulously, as patients with diabetes insipidus require careful perioperative fluid management to prevent both dehydration and fluid overload. 6

Additional Pituitary Axes

• Measure TSH and free T4 to detect central hypothyroidism, which occurs in 2.8–29.2% of patients (higher rates when empty sella is symptomatic versus incidental). 1, 2
• Assess gonadotroph axis (LH, FSH, testosterone/estradiol) as hypogonadism is present in 8.5–50.4% of cases. 1
• Check serum prolactin to identify hyperprolactinemia (2.9–15.7% prevalence) or stalk effect. 1, 2
• Measure IGF-1 to screen for growth hormone deficiency, found in 12.5–20.4% of patients. 1, 2

Intraoperative Management Considerations

Hemodynamic Monitoring and Support

• Anticipate vasodilatory hypotension, particularly in patients with undiagnosed vasopressin insufficiency, which may not respond to conventional fluid resuscitation and inotropic therapy. 3
• Have exogenous vasopressin immediately available for refractory hypotension, as case reports document profound vasodilatory shock in empty sella patients that rapidly corrected only with vasopressin infusion. 3
• Expect gradual blood pressure decline with neuraxial anesthesia (e.g., systolic pressure decreasing from 120 to 90 mmHg), though this is typically manageable without vasoconstrictors if adrenal function is adequate. 6

Anesthetic Technique Selection

• Neuraxial anesthesia (spinal or epidural) can be performed safely when there is no evidence of increased intracranial pressure, as documented in successful case reports. 6
• Exclude elevated intracranial pressure preoperatively, as some empty sella patients have chronically elevated ICP (though many have normal pressures), and neuraxial techniques could theoretically precipitate herniation if ICP is significantly elevated. 7
• General anesthesia is appropriate but requires vigilant hemodynamic monitoring given the risk of unmasking pituitary hypofunction under metabolic stress. 3

Fluid Management

• Restrict perioperative fluid administration carefully in patients with diabetes insipidus on desmopressin, as the case literature documents minimal intraoperative urine output (25 mL over 80 minutes) with appropriate desmopressin coverage. 6
• Balance fluid replacement to avoid both hypovolemia (which exacerbates hypotension in adrenal insufficiency) and fluid overload (which can occur with desmopressin therapy). 6

Risk Stratification

High-Risk Features

• Male sex, clinical suspicion of pituitary disease, and history of traumatic brain injury significantly increase the likelihood of hypopituitarism (P = 0.02, P <0.001, P = 0.003 respectively). 1, 2
• Total empty sella (versus partial) confers greater risk of hormone deficiency. 1
• Progression from partial to total empty sella correlates with hormonal deterioration (P = 0.006). 1, 2

Symptom Absence Does Not Exclude Risk

• Do not rely on absence of symptoms to exclude hormone deficiency, as the negative predictive value of symptom absence is only approximately 71%, and 29% of asymptomatic patients still have hormone deficits. 4, 1, 2

Postoperative Monitoring

• Continue stress-dose corticosteroids for 24–48 hours postoperatively in patients with confirmed or suspected adrenal insufficiency, tapering as clinically appropriate. 1
• Monitor for postoperative complications including CSF rhinorrhea, which can occur rarely in empty sella patients. 4, 8
• Assess for neurological deficits postoperatively, though these are uncommon with appropriate anesthetic management. 6

Critical Pitfalls to Avoid

• Never assume normal pituitary function based solely on symptom absence, as up to 40.5% of incidentally discovered empty sella patients have at least one hormone deficiency. 4, 1
• Do not overlook adrenal insufficiency screening, as hypocortisolism rates are comparable in incidental (13.5%) and symptomatic (17.7%) presentations and can be lethal if missed perioperatively. 1, 2
• Avoid attributing all hypotension to anesthetic technique or hypovolemia—consider vasopressin insufficiency if hypotension is refractory to standard interventions. 3
• Do not proceed with elective surgery without endocrine evaluation in patients with known empty sella, as undiagnosed hormone deficiencies pose significant perioperative risk. 1, 2